MannKind expands pipeline with $350M acquisition
Westlake Village-based MannKind Corporation is expanding its pipeline by acquiring scPharmaceuticals, a Massachusetts-based biotech company that specializes in cardiorenal medicine, for $360 million, or $5.35 per share. Announced before the markets opened Aug. 25, MannKind shares ticked up about 1% in pre-market trading. Shares ultimately settled at $3.90 on Aug. 25, about 3.1% down. Shares Read More →
Atara shares up behind slew of good news, earnings
Shares of Thousand Oaks-based Atara were seemingly in free-fall mode for much of the year, but over the past month, the company has racked up the wins and analysts and investors are taking note. Most recently, Atara, a biotechnology company with two facilities in Thousand Oaks, announced its earnings results for the second quarter of Read More →
Sonos shares tick up behind optimism
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Healthcare providers sue Amgen for alleged trade restraint
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Funding success: Santa Barbara Venture Partners closes $25M fund
Local venture capital firm Santa Barbara Venture Partners had a solid run with its first fund. According to the firm, its first fund saw some investments pay off, with huge increases in valuation and even a handful of exits. Thanks to that success, Santa Barbara Venture Partners was also able to recently announce the closing Read More →
MannKind inks $500M financing agreement with Blackstone
Westlake Village-based MannKind Corporation is receiving some extra help to advance some of its short and long-term growth strategies. Announced Aug. 6, MannKind, a biotech company focused on inhaled therapeutic products, entered into a financing agreement worth up to $500 million with Blackstone, the world’s largest alternative asset manager, with more than $1 trillion in Read More →
Update: The Trade Desk shares plummet 38% after Q2 earnings
Editor’s note: This story was updated on Aug. 8 to reflect The Trade Desk’s share price at close of day. Shares of The Trade Desk, an advertising tech company based in Ventura, fell as much as 29% in after-hours trading on Aug. 7 following the company’s announcement of its second-quarter earnings. Shares fell even lower Read More →
